Financial Services
Translational Development Acquisition Corp.(TDAC)
Live Price
Offline$10.72
+0.00% today
1Y Change
+4.67%
Window
Jun 20, 2025 โ Jun 18, 2026
- Market Cap
- $230.00M
- Revenue Growth
- -100.0%
- EPS Growth
- +2384.0%
- Dividend Yield
- 0.0%
Coverage: 251 bars ยท Jun 20, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Translational Development Acquisition Corp. (TDAC) is a Financial Services stock with a market cap of $230.00M and listed on NASDAQ. The stock last traded around $10.72 and up 4.7% across the available one-year price window (Jun 20, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +2384.0%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +2384.0%, free cash flow +28.5% with operating margin 0.0% and ROIC -0.5%. Valuation sits in the middle of the pack at P/E 28.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TDAC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-100.0% vs +3.4% peer median
Operating Margin
Below sector median
0.0% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 15, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -100.0% and EPS is at +2384.0%, with operating margin around 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 15, 2026 | โ | +0.0% | +0.0% | +0.8% |
2026 Mar 16, 2026 | โ | +0.0% | +0.3% | +0.6% |
2021 Sep 30, 2021 | โ | +0.0% | +0.0% | +0.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TDAC
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TDAC Max Drawdown
-0.56%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TDAC and SPY.
Company Overview
Translational Development Acquisition Corp.
NASDAQ Capital Market
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
- Leadership
- Michael Hoffman
- IPO Date
- Feb 20, 2025
- Employees
- 2
- Street Address
- 77 Water St Fl 8
- Mailing
- New York City, NY, 10006
- Region
- New York City, NY, US
- Reporting Currency
- USD
- Investor Line
- 16462297549
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 28.8
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- 1.0
Growth
- Revenue
- -100.0%
- EPS
- +2384.0%
- Free Cash Flow
- +28.5%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 3.7%
- ROIC
- -0.5%
Balance Sheet
- Debt/Equity
- 0.00
- Current Ratio
- 0.07
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.